Nuvalent, Inc. NUVL
Set alert
123.96 USD 0.00 0.00%
As of Jul 15, 9:30 AM ET
123.96 Day range 123.96
87.30 52-week range 123.99
- YTD
- +23.23%
- 1 year
- +56.65%
- Open
- 123.96
- Prev close
- 123.96
- Mkt cap
- 9.13B
- Vol
- 0
- Avg vol
- 1.93M
- EPS
- -6.06
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 123.96
- High
- 123.96
- Forward P/E
- -29.34
- Beta
- 1.14
- Short ratio
- 0.56
- Inst. own
- 113.30%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2026
- 50-d avg
- 114.66
- 200-d avg
- 105.26
- 1y target
- 124.00
Analyst view
Consensus: hold
Hold
Price target (mean) 124.00
Ratings (0m) 9 0 buy · 9 hold · 0 sell
- Strong buy0
- Buy0
- Hold9
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 17
- 2 months ago 20
- 3 months ago 19
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.38 | -1.48 – -1.13 | -1.39 | +0.9% | 0 | 0.0% | 9 |
| Next quarter | -1.40 | -1.57 – -1.21 | -1.70 | +17.6% | 1.40M | 0.0% | 9 |
| Current year | -5.50 | -6.37 – -4.69 | -5.85 | +5.9% | 10.74M | 0.0% | 10 |
| Next year | -4.02 | -5.49 – -2.84 | -5.50 | +27.0% | 181.03M | +1586.1% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 24, 2026 | Bernstein | Downgrade | Outperform | Market Perform |
| Jun 10, 2026 | Truist Securities | Downgrade | Buy | Hold |
| Jun 10, 2026 | TD Cowen | Downgrade | Buy | Hold |
| Jun 10, 2026 | Barclays | Downgrade | Overweight | Equal-Weight |
| Jun 10, 2026 | Wedbush | Downgrade | Outperform | Neutral |
| Jun 10, 2026 | UBS | Downgrade | Buy | Neutral |
| Jun 10, 2026 | Guggenheim | Downgrade | Buy | Neutral |
| Jun 9, 2026 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Jun 9, 2026 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Jun 9, 2026 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Jun 9, 2026 | Wedbush | Downgrade | Outperform | Neutral |
| Jun 9, 2026 | LifeSci Capital | Downgrade | Outperform | Market Perform |
| May 28, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| May 22, 2026 | Bernstein | Initiated | — | Outperform |
| Apr 21, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 8, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Mar 30, 2026 | Wells Fargo | Initiated | — | Overweight |
| Feb 27, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Dec 19, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 24, 2025 | Truist Securities | Initiated | — | Buy |
| Nov 18, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Nov 18, 2025 | Baird | Maintained | Outperform | Outperform |
| Nov 18, 2025 | Guggenheim | Maintained | Buy | Buy |
| Nov 17, 2025 | Stifel | Maintained | Buy | Buy |
| Nov 17, 2025 | Leerink Partners | Maintained | Outperform | Outperform |
| Nov 17, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 12, 2025 | Canaccord Genuity | Initiated | — | Buy |
| Oct 31, 2025 | Barclays | Maintained | Overweight | Overweight |
| Oct 31, 2025 | UBS | Maintained | Buy | Buy |
| Oct 27, 2025 | Piper Sandler | Maintained | Overweight | Overweight |